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West Nile virus (WNV) is an important arthropod borne flavivirus; usually causes a mild infection
called West Nile fever (WNF) in human and horses. Mosquitoes are the principal vectors of WNV.
Various Culex species are found to act as vectors in different geographical regions. The virus is
maintained in a bird-mosquito cycle in nature. In India, Culex mosquitoes are tentatively incriminated
as vectors of WNV. Experimental studies have shown that Culex tritaeniorhynchus, Cx. vishnui,
Cx. bitaeniorhynchus and Cx. univittatus, Culex pipiens fatigans and Aedes albopictus could act as potential
vectors of WNV. Transovarial transmission of WNV has been experimentally demonstrated in Culex
mosquitoes. Apart from mosquitoes, the role of other arthropods is also considered in the maintenance
of WNV during inter-enzootic periods. The possible role of ardeid birds in the maintenance of WNV
has been described in India. Though very few clinically overt cases of human encephalitis due to WNV
are observed, Japanese encephalitis virus (JEV) is found to dominate in southern India. WNF in horses
has not been documented in India. JEV immunized monkeys were protected from WNV challenge and
the WNV immunization was found to reduce the disease severity due to JEV. Based on the limited
genome sequence analysis, the Indian isolates are grouped together under the genetic lineage-I. WNV
infection is diagnosed by IgM antibody capture enzyme linked immunosorbant assay,
haemagglutination inhibition test, neutralization test and reverse transcriptase-polymerase chain
reaction (RT-PCR). For the effective control of Culex mosquitoes, integrated vector control strategies
are recommended. Specific methods are not available for the treatment of WNV infection. However, in
patients with encephalitis supportive therapy is recommended. Though a few candidate vaccines are
under laboratory trial, no vaccine has been available commercially for the control of WNV infection in
human and animals. In view of the global interest on WNV, this paper describes the present status of
WNV in India.
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West Nile virus (WNV) is an arthropod borne virus
of public health importance. WNV is a member of the
genus flavivirus and belongs to the Japanese encephalitis
virus (JEV) antigenic complex under family flaviviridae.
The other members of the serocomplex are Japanese
encephalitis, Murray Valley encephalitis, Alfuy, Kokobera,
Koutango, St. Louis encephalitis, Stratford and Usutu.
Kunjin Virus which was considered closely related to
WNV1, has recently been classified as a sub type of
WNV2.
WNV infection is a self-limited, non-fatal mild febrile
illness but occasionally reported to cause encephalitis3.
It causes mortality in horses4, domestic and wild birds3.
The emergence of WNV in America5 and its impact on
the health of humans, horses and birds, have caused global
concern about this virus. In India, this virus is known to
be active in mosquitoes, birds and pigs. It has also been
associated with human encephalitis cases6. Therefore,
it is felt necessary to review the present status of WNV
in context with Indian scenario.
Natural cycle
WNV is reported to be maintained in the nature in a
cycle involving certain birds and mosquitoes7. Mosquitoes
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are principle vectors of WNV. Outbreaks of WNV
infection coincided with the increased population of the
Culex mosquitoes during summer in temperate regions
and during rainy seasons in tropics8. This virus has been
mainly isolated from Cx. univittatus in Egypt9 and
South Africa10; Cx. pipiens and Cx. perexiguus in
Israel11; and from Cx. molestus in France12; Cx. vishnui
complex in Pakistan13; Cx. restuans, Cx. pipiens,
Culiseta melanura and Cx. salinarius in Connecticut,
USA14. The role of non Culicine arthropods has also
been considered in the maintenance of WNV during
inter-enzootic periods. WNV has also been isolated from
both hard and soft ticks (Hyalomma marginatum,
Omithodoros maritimus, Argas hermanni,) and
swallow bugs (Oeciacus hirundinis)3. Experimental
transmission of WNV has been observed in
Ornithodoros savignyi, O. maritimus, O. moubata,
O. erraticus, Rhipicephalus sanguines, R. rossicus,
Dermacentor reticulatus and Haemophysalis leachii15.
In India, this virus has been isolated from human
beings6,16,17, frugivorous bat18 (Rousettus leschenaulti),
domestic pigs (NIV, unpublished data) and mosquitoes19-21.
The WNV isolate (724268) was recovered from a pool
of 100 Cx. vishnui mosquitoes, collected resting outdoors
in bushes at Mudikonda village, Khammam taluk,
Khammam district, Andhra Pradesh19. In another study,
two strains of WNV have been isolated from two pools
(pool size 48 and 50 females respectively) of Cx. fatigans
(Cx. quinquefasciatus) at Manjri, Pune20. Of 5553
Cx. vishnui mosquito pools (containing 738, 291
mosquitoes), Dandawate et al21 isolated five strains of
WNV from five pools with a pool sizes ranging from 74
to 150 mosquitoes collected from North Arcot districts
of Tamil Nadu and Chittoor district of Andhra Pradesh.
Experimental studies have shown that mosquitoes viz.,
Cx. tritaeniorhynchus, Cx. vishnui,
Cx. bitaeniorhynchus and Cx. univittatus22,
Cx. pipiens fatigans (Cx. quinquefasciatus) and
Aedes albopictus23 could act as potential vectors of
WNV. Transovarial transmission (TOT) of WNV has
been experimentally demonstrated in Cx. vishnui
mosquito24.
Several birds in different geographical regions have
been implicated as vertebrate reservoirs viz., passerine
birds in North America, house sparrow in Europe, hooded
crow and other birds in Africa, turtle dove in Middle
east and herons in Oceania3. In southern India,
JEV/WNV neutralizing antibodies were detected in
ardeid birds mainly from the pond herons
(Ardeola grayii) and cattle egrets (Bubulcus ibis). This
indicates the possible involvement of ardeid birds in the
natural cycle of WNV in India25. Experimental infection
of equines with WNV has been reported
previously26-29. A recent study30 has shown that horses
cannot act as amplifying host of WNV in nature. In
southern India, domestic pigs were shown to develop
antibodies to WNV31, but are considered poor hosts32.
Geographical distribution
WNV is recognized as the most widespread virus
among flaviviruses. It was first isolated during 1937 in
the West Nile district of Uganda from a patient suffering
from mild illness33. WNV has been reported from
Algeria, Russia, Azerbaijian, Botswana, Central African
Republic, Cote d’lvoire, Cyprus, Democratic Republic
of Congo, Egypt, Ethiopia, Israel, Kazakhstan,
Madagascar, Morocco, Mozambique, Nigeria, Pakistan,
Senegal, South Africa, Tajikistan, Turkmenia, Uganda
and Uzbekistan15. Several epidemics have been
reported from middle East, Africa and Israel and the
WNV is endemic in Middle East, Africa and Southwest
Asia34,35. WNV specific neutralizing antibodies have
been detected in Armenia, Borneo, China, Georgia, Iraq,
Uganda, Kenya, Lebanon, Malaysia, Philippines,
Sri Lanka, Syria, Thailand, Tunisia, Turkey Belgian
Congo and Sudan15,34. Recently, the virus has been
recognized in New York, America5.
In India, presence of West Nile antibodies in humans
was first reported from Bombay (now Mumbai) by
Banker in 195236. Smithburn et al37 confirmed the report
by detecting the WNV neutralizing antibodies. During a
post sero-epidemiological study, Risbud et al38, detected
WNV neutralizing antibodies among humans at South
Arcot district of Tamil Nadu. WNV has been isolated
from sporadic cases of encephalitis and mosquitoes.
Work39 postulated a hypothesis of a zoogeographical
interface of Japanese encephalitis and West Nile virus.
The hypothesis proposed the intermingling distribution
of JEV and WNV at the south Indian peninsular region.
The relative prevalence of JEV and WNV needs to be
studied in India. From the available data, it is evident
that different viruses may predominate in different years
since in South Arcot District of Tamil Nadu,
INDIAN J MED RES, SEPTEMBER 2003
103
Risbud et al38 observed a higher prevalence of
neutralizing antibodies to WNV than JEV during a post
encephalitis outbreak survey in 1982, whereas in the
same area, during 1989 and 1990, Gajanana et al40 found
a low prevalence of WNV.
Biological characterization
Strain analysis studies have been reported
earlier41-45. The prevalence of similar antigenic strains
and a single heterogeneous domain based on epitope
mapping of envelope protein among Indian strains were
reported46. The study on understanding the nature of
passive immunity in WNV infected mice elucidated the
transfer  of maternal antibodies through placenta and
colustrum47. Two-way cross protection studies between
JEV and WNV revealed that the JEV immunized
macaque was protected from WNV challenge. On the
other hand, WNV immunization only reduces the disease
severity due to JEV48. Recently, Tesh et al49
demonstrated that immunization with heterologous
flaviviruses (JEV and St. Louis encephalitis virus)
protects hamsters against WNV challenge by reducing
the severity from fatal encephalitis.
The comparative analysis of the degree of
pathogenecity among Indian isolates of WNV in mice,
and their plaque size in cell culture were studied50. A
varying degree of pathogenecity was observed in adult
mice by the peripheral route. Among the six strains
studied, bat (68856) and human strains (672698) were
found to produce smallest and largest plaques
respectively. A serological heterogeneous group has been
observed among Indian WNV isolates. The poor
immunogenecity of the human isolate and poor
antigenecity in serological testing of a mosquito isolate
(643009) were also observed51. The study also reported
the non-identical nature of the two mosquito isolates
G2266 and G22886 though appear similar.
Genomic characteristics
WNV are small spherical, enveloped particles
containing single-stranded positive-sense RNA genome.
The viral genome is approximately 11,000 nucleotides in
length. The viral genome encodes for three structural
(C, M and E) and seven non-structural (NS1, NS2a,
NS2b, NS3, NS4a, NS4b and NS5) proteins. It has a
single large open reading frame (ORF), flanked by
non-coding regions (NCR) at both the ends52. The
mosquito borne flaviviruses lack poly (A) tail at its 3’ end53.
WNV is mainly divided into two genetic lineages,
namely lineage-1 and lineage-2. The strains grouped
under lineage-1 are associated with human clinical
encephalitis. The members of the lineage-2 have not
been found to be associated with human encephalitis
and are maintained in enzootic foci in Africa34. Genome
characterization of WNV has been previously
described54-59. Phylogenetic study conducted among the
isolates recovered from Europe and Africa suggested
the introduction of WNV into Europe by birds migrating
out of sub-Sahara Africa55.
The available data on the genomic sequences of
Indian WNV isolates are limited. Porter et al54 analyzed
the NS3 region of the Indian bat isolate (68856) and
compared with six other WNVs recovered from
different geographical regions. In the reverse
transcriptase-polymerase chain reaction (RT-PCR)
assay, the expected PCR product of the bat isolate
(258-bp) was found to be less distinct compared to the
other strains studied. The analysis showed that the
twelve bases of the 5’ primer-binding site of the Indian
bat isolate showed a 25 per cent mismatches than the
AME (Asian Middle East group) group strains (0-16%).
In the PCR product nucleotide sequence analysis the
Indian isolate-shared 92-98 per cent sequence
homology with other isolates i.e., E-101, AN4767,
AN4766 and Dak B310. The interesting point is that
all the five other strains (including 68856) showed only
77-82 per cent homology with the WNV  Nigerian strain
(WN-Wengler). Based on the E and NS5/3’UTR gene
region analysis, the Indian isolates (G-2266 and G-22886
mosquito isolates, and 804994 a human isolate) were
grouped in the lineage-I58. These strains were further
grouped with one of the three clusters of lineage-I.
The isolates grouped under lineage-I shared an average
sequence identity of 80 per cent (E gene) and
77 per cent (NS5/3’UTR). The Indian isolates are
clustered together. They shared an average sequence
identity of 97 per cent and 98 per cent in the E region
and NS5/3’UTR regions respectively58. However, the
analysis of very limited number of isolates, may not
represent the complete picture of the molecular
epidemiology of WNV in India.
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Epidemiology
WNV is an emerging virus infection of the globe.
Several outbreaks in different countries with various
range of severity has been reported earlier5,11,15,35,60. The
first known outbreak of WNV in the northern United
States was observed during late August 19995 and due
to the widespread virus activity, Northeastern USA is
becoming endemic to WNV61. In human, clinically WNF
appears as a mild, self limited, non-fatel, febrile illness
rarely leading to encephalitis. However, myocarditis, a
rare non-neurological complication62 and pancreatitis
associated WNV infection63 have also been reported.
In monkey model, WNV has been reported to cause
persistent infection and a sub acute inflammatory
degenerative processes in the nervous system64.
WNV is highly prevalent in India65 and usually causes
a mild, non-fatal dengue like illness in humans. However,
febrile illness in epidemic form and clinically overt
encephalitis cases were observed in Udaipur area of
Rajastan, Buldhana, Marathwada and Khandesh districts
of Maharashtra66. WNV neutralizing antibodies (about
20-30%) have been detected in human sera collected
from Tamil Nadu, Karnataka, Andhra Pradesh,
Maharashtra, Gujarat, Madhya Pradesh, Orissa and
Rajastan67. Serologically confirmed cases of WNV
infections were reported from Vellore68 and Kolar
districts during 1977, 1978 and 19816. The incubation
period is 1 to 6 days. The WNV strain P-4230 has been
isolated from a laboratory worker who got lab infected
while handling the Indian mosquito strain G-2266 and
the Egyptian human strain E-101 on consecutive two
days (Virus Research Centre, Annual Report-1956).
However, as WNV was prevalent in Pune area, the
source of infection could not be ascertained69.
Horses encounter the WNV infection like humans
and experience encephalitis. Though the WNV
encephalitis in horses is rare, a considerable mortality
rate is reported in the case of encephalitic horses. WNV
fever in horses has been reported in Egypt26, France4,
Morocco70, Italy71 and in USA72. WNV infection in
horses has not been documented in India. However in a
recent survey, a significant rate of serological evidence
against WNV has been noticed among horses in and
around Pune City (NIV; unpublished data). Extensive
studies of WNV infection in horses in India need to be
carried out.
Laboratory diagnosis
WNV infection is diagnosed by serological methods.
Demonstration of four-fold rise or drop of antibody titer
in paired serum samples by heamagglutination inhibition
test in still widely used73. The interference of cross-
reactions of the co-existing other closely related virus
especially JEV has been reported. In a single human
serum sample MAC (IgM-antibody capture) ELISA is
routinely used for the diagnosis of acute infection in
human74. A commercially available arboviral
immunofluorescence assay has been used for the
screening of West Nile virus infection in human75. The
commercially available West Nile virus specific
monoclonal antibody (MicroBix Bio system INC,
Canada) could be exploited in the detection of the virus.
Quick complement fixation test76, kinetic complement
fixation test77, single radial haemolysis test78 and
neutralization test79 are some of the tests which are
routinely used. Plaque reduction neutralization test is
very useful in survey and confirmation of virus isolates73.
Recently, the RT-PCR method for the detection of virus
specific genome has been extensively used by several
workers80-82. To increase the sensitivity and specificity
certain modified assays viz., TaqMan assay80 and nucleic
acid sequence based amplification method (NASBA)83
have been reported. The TaqMan assay has been
successfully used for the detection of WNV in human
(cerebrospinal fluid) CSF that was found negative in
conventional cell culture technique80. The other NASBA
method involves the use of three enzymes and a detection
system of electrochemiluminescence (ECL). Alternately,
molecular beacon probes have also been used as
detection system83. However, the test requires real time
PCR machine.
Prevention, treatment and control
The guidelines for detection, prevention and control
of WNV in the United States of America have been
published84 and are available in the internet (http://
www.cdc.gov/ncidod/dvbid/westnile/publications.htm).
In India, since no studies have been carried out for the
control of WNV, the strategies recommended for control
of Culex mosquitoes, the known vectors of JEV could
be applicable. The integrated vector control strategies
includes the use of personal protection measures like
protective clothing, bed nets, both chemical and neem
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based repellants, insecticides, insecticide impregnated
curtains, and biological control methods by larvivourus
fish, introducing natural parasites and predators and
bacterial agents85. In clinically overt cases, specific
methods are not available for the treatment of WNV
infection. However, in encephalitis cases supportive
therapy is recommended3. Several drugs have been tried
for the treatment of encephalitis in animal models86-90.
The encouraging result of an appetite stimulant91 and
intravenous administration of donor immune serum
against WNV in severe human cases has been
described92. Though a few candidate vaccines are under
laboratory trial93, no vaccine is available commercially
for the control of WNV infection in human and animals.
Conclusion
WNF is not a new disease to India. The recent
emergence of WNV in America has clearly indicated
the spread of WNV to newer areas. The spread of US
strain of WNV to India may not create an impact as the
circulation of WNV among Indian population has been
well documented. Along with WNV, the coexisting
closely related JEV could also expected to provide a
limited cross protection to the community. The possible
threat of spread of US WNV strain to Australia has
been addressed94, where the circulation of Kunjin virus
(a sub type of WNV) and the closely related JEV and
Murray Valley encephalitis virus (MVE) is known.
Inclusion of molecular diagnostic methods for the
accurate diagnosis of WNV infection could probably
improve the surveillance of WNV in India, where other
closely related flaviviruses coexist.
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